Dongguan Senear Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Dongguan Senear Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DIELIYA. The owner is based in Guangdong Province.
1112, Building 1, No.16 Keji 4th Road
Songshanhu Park, Dongguan City
Guangdong Province 523000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Dongguan Senear Technology Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Dongguan Senear Technology Co., Ltd. have?
Dongguan Senear Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Dongguan Senear Technology Co., Ltd. file in?
Dongguan Senear Technology Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Dongguan Senear Technology Co., Ltd.'s most well-known trademarks?
Dongguan Senear Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as DIELIYA. These are among 1 currently registered trademark in the portfolio.
What is Dongguan Senear Technology Co., Ltd.'s trademark registration success rate?
Dongguan Senear Technology Co., Ltd. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.